In the past decade, women’s health supplements category grew at a CAGR of 10% globally. With increasing life expectancy, women spend about 30% to 40% of their lives in post-menopause period. The symptoms of menopause can be distressing and can considerably affect the quality of their personal, social, and work life.
Euromonitor Plc confirmed that women’s health is the 2nd fastest growing dietary supplement category between 2011 and 2020.
Around 33% of perimenopausal women already take supplements to address their health. Many of them use supplements to alleviate menopausal symptoms and this is expected to grow in the future. It is no coincidence that Pharmavite, i-Health (DSM), and PharmaCare all own supplement brands, exclusively dedicated to menopause.
PharmaLinea is introducing its latest nutraceutical innovation – ‘>Your< Meno Ease Capsules’ – presenting an opportunity for science-based brands to address the thriving menopause market.
According to Maja Oresnik, Science & Research Director at PharmaLinea, “There are various branded ingredients promoting optimal women’s health during the menopausal transition, but rarely any combination of them offers improvement in typical symptoms as well as other health areas while following various regulatory requirements around the globe. Our new formulation is a combination of a recognised natural ingredient with proven benefits in menopausal health and an active molecule originating from an innovative yeast fermentation process.”
Matevz Ambrozic, Marketing & PR Director at PharmaLinea added, “A new, 2nd generation of women’s health products is coming in with branded clinically studied ingredients and looking at wider health systems. Not only menopause symptoms but also bones, mood, cognitive, and pain. Our new product is a representative of this wave.”
‘>Your< Meno Ease Capsules’ are a natural clinically supported solution for menopausal and post-menopausal population that present an advanced differentiation in an established market.. They provide overall symptom relief and additional benefits such as mood, cognition, pain perception, cardiovascular, and bone density.
>Your< Meno Ease Capsules are a better version of a classic menopause product – they are a defined formulation of branded ingredients with best-quality, clinically supported sources of recognised ingredients resveratrol and soy, and have various health benefits for various positioning options.
Maja said that women’s health is often addressed by traditional herbal products which have a long history of use by default, but modern science is?struggling to confirm their efficacy and safety.?Many products currently available in the market consist of basic vitamins and minerals.?Many are also using traditional plants (soy,?black cohosh, barley etc) from commodity?sources. We were trying to find a solution,?that is supported by high-quality scientific ?research.
In menopause, effectiveness need to be felt by consumers or there will be no second purchase, said Ambrozic. The best chance for efficacy is branded and clinically studied ingredients. Also, safety and purity can be questionable in some of the regularly used plant ingredients, so traceable high-quality branded sources are an advantage. Products in the premium, clinically supported segment are suitable for promotion through doctor recommendations and are especially successful in developed markets.
Clinically studied ingredients in PharmaLinea latest product:
A branded top quality soy ingredient with studies on overall menopause symptom relief and improvement of quality of life. Soy is a typical menopause ingredient, very well recognised in the space, and this is one of the best sources.
A branded resveratrol with studies on the additional mentioned benefits: cognition, risk of cardiovascular diseases, bone density, mood, and pain perception.
PharmaLinea is a European-based private label food supplements manufacturer. It provides clinically supported supplements that truly solve consumer needs and bring its partners’ brands to leading positions. It invests heavily in clinical trials on its products and in rigorous stability testing.